Qualification: AI-tool for prostate pathology at St. Olavs Hospital Trust

Hankinnan yleistiedot

eForm 16 Contract notice — standard regime
Kilpailullinen neuvottelumenettely
24.4.2025 10.53 (GMT+03:00)
28.5.2025 13.00 (GMT+03:00)
Ei

Hankintayksikkö

SYKEHUSINNKJØP HF SYKEHUSINNKJØP HF
Frida Rekstad Frida Rekstad
Postboks 40
Tollbugata 7

9811 VADSØ
Norja
916879067

Määräaika on umpeutunut

Lyhyt kuvaus

Helse Midt-Norge (Central Norway Health Authority) is the first region in Norway to use digital pathology for routine diagnostics in pathology.

The two pathology departments, St. Olavs Hospital and Ålesund sykehus, use the same scanners (Hamamatsu and Philips), the same laboratory information and management system (LIMS, Sympathy) and image management system (IMS, Philips).

Currently many different AI tools and image analyses software packages have been CE-IVD approved for use in clinical routine practice, but until now very few pathology departments have implemented these computer-aided diagnostic (CAD) tools in daily clinical practice.

The two pathology departments in Helse Midt-Norge aim to implement AI tools to enhance the efficiency, speed and objectivity of pathology diagnostics. More importantly, patients will benefit from superior tissue diagnostics that forms the basis for personalized treatment.

To start the AI-tool journey the short-term goal is to purchase and implement an AI tool for automatic detection and grading of prostate cancer. Helse Midt-Norge’s IT organisation, Hemit HF, will be an important partner for successful integration with our IMS.

Tämä on kaksivaiheinen hankinta. Tästä linkistä voit nähdä toisen vaiheen tiedot ja tiedostot: AI-tool for prostate pathology at St. Olavs Hospital Trust

Mercell Suomi Oy

Osa Mercell-ryhmää, Euroopan johtavaa hankintapalvelujen sekä sähköisen kilpailutusjärjestelman tuottajaa.

Yleistä hankinnoista

Hankintalaki
TED

Yhteydenotto

Klikkaa tästä asiakaspalveluun

+358 207 661 072